Search Results
Dr. Tolaney on the Evolution of Adjuvant Treatment for HER2+ Breast Cancer
Dr. Tolaney on the Evolution of Treatment in HER2+ Breast Cancer
Dr. Tolaney on Navigating Adjuvant Therapy in Early-Stage HER2+ Breast Cancer
Dr. Tolaney on the Neoadjuvant Therapy for HER2-Positive Breast Cancer
Dr Sara M. Tolaney Discusses the Role of Adjuvant Therapy in HER2-Positive Breast Cancer
Dr. Tolaney on the Current Treatment Landscape for HER2+ Breast Cancer
Dr. Sara Tolaney on Adjuvant T-DM1 Vs Paclitaxel and Trastuzumab for Stage I HER2+ Breast Cancer
Dr. Tolaney on Novel Approaches in Treating HER2-Positive Breast Cancer
Dr. Tolaney Discusses Neratinib in HER2+ Breast Cancer
Dr. Hamilton on the Evolution of Treatment in HER2+ Breast Cancer
The evolution of HER2 targeting in metastatic breast breast cancer
Case 1: Adjuvant Therapy for Residual Disease in HER2+ Breast Cancer
